Global Trends and Politics
(CVS) stock rises

The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada, on Feb. 7, 2024.
After a dismal 2024, CVS Health could be starting to turn itself around. Some investors seem convinced, especially after the retail drugstore chain posted a big beat on fourth-quarter earnings and a 2025 profit outlook that was in line with expectations.
Shares of CVS are now up more than 45% for the year, unlike the company’s main retail pharmacy rival Walgreens, whose stock is up nearly 3%. Shares of other insurers UnitedHealth Group and Cigna are up about 4% and nearly 8%, respectively.
The upbeat quarterly results may be a sign that brighter days are ahead for CVS – or at least that things may not be as bad as they were last year. The company’s stock plummeted more than 40% in 2024 after it missed earnings estimates for three straight quarters and withdrew its annual forecast, largely due to higher-than-expected medical costs in its insurance unit, along with other issues like pharmacy reimbursement pressure.
CVS isn’t out of the woods yet. Medical costs were less severe during the fourth quarter but will likely remain elevated in 2025, as more seniors flock to hospitals and doctor’s offices and use more health-care benefits.
But some analysts are more optimistic about the company’s ability to navigate those challenges moving forward and reach its full-year 2025 adjusted earnings outlook of $5.75 to $6 per share. CVS has pursued store closures and other cost cuts, and its new CEO David Joyner has spent much of his first 100 days at the helm focusing on the company’s insurance unit Aetna.
"The pieces are in place for [CVS to return] from what has been a bottoming of operations performance," said Leerink Partners analyst Michael Cherny, who upgraded the stock on Wednesday after the results.
Cantor Fitzgerald analysts on Wednesday also upgraded CVS’ stock, citing "increased confidence in a successful turnaround."
Insurance Business Woeful
CVS has already taken steps to rightsize its insurance business, which includes plans for the Affordable Care Act, Medicare Advantage and Medicaid, as well as dental and vision. The company exited certain unprofitable health plans in 2024, and hiked premiums to enroll fewer members this year.
In a research note, Cantor Fitzgerald analysts said they are "incrementally more confident" that CVS will improve margins in its Medicare Advantage business and return to "normal levels" by 2027.
CVS has said it wants to get the Medicare Advantage business back to a 3% to 5% margin. They were in the negative 4.5% to 5% range at the end of 2024, CVS CFO Tom Cowhey said during an earnings call on Wednesday.
CVS and other insurers such as UnitedHealth Group and Humana have seen medical costs spike over the last year as more Medicare Advantage patients return to hospitals for procedures they delayed during the pandemic.
Medicare Advantage Challenges
Medicare Advantage, a privately run health insurance plan contracted by Medicare, has long been a driver of growth and profits for insurers. But investors have become concerned about the runaway costs tied to those plans, which cover more than half of all Medicare beneficiaries.
To improve margins, the company plans to shrink Medicare Advantage membership by a "high single-digit percentage" from the end of 2024, executives said on Wednesday. Aetna had 4.4 million Medicare Advantage members as of December, up from 3.5 million the year before, according to the company’s fourth-quarter release.
Overall, CVS executives said they expect to decrease insurance members by more than 1 million this year, including 800,000 in the individual market. Patients who lose insurance can enroll in a new Medicare Advantage plan or join traditional Medicare plans.
Aetna also scored better Medicare Advantage star ratings for the 2025 payment year, which should boost its federal payments in 2026. Those crucial ratings help patients compare the quality of Medicare health and drug plans and determine how much an insurer receives in bonus payments from the Centers for Medicare & Medicaid Services.
CVS Stock Outperforms Rivals
Shares of CVS are outperforming most of its health-care rivals, both on the insurance and retail pharmacy sides. Jefferies analyst Brian Tanquilut said that is likely due to CVS’ unique position as a company that owns a health insurer, a retail drugstore chain, and a pharmacy benefit manager, or PBM, called Caremark.
"I think what they’re starting to show is the real synergy…in owning all three assets," Tanquilut said.
PBMs such as Caremark sit at the center of the drug supply chain in the U.S., negotiating drug rebates with manufacturers on behalf of insurers, creating lists of preferred medications covered by health plans, and reimbursing pharmacies for prescriptions.
That means Caremark also sits at the intersection of CVS’ retail pharmacy operation and its Aetna insurer, boosting the competitive advantage of both of the businesses.
Conclusion
CVS is showing signs of turning itself around after a dismal 2024. While medical costs will likely remain elevated in 2025, the company’s unique position in the health-care industry could be paying off. With its insurance, retail pharmacy, and PBM businesses working together, CVS may be well-positioned to outperform its rivals in the years to come.
FAQs
Q: What is the current stock performance of CVS?
A: Shares of CVS are up more than 45% for the year.
Q: How is CVS’ insurance business performing?
A: The company is working to rightsize its insurance business, which includes plans for the Affordable Care Act, Medicare Advantage, and Medicaid, as well as dental and vision.
Q: What are the challenges facing CVS’ Medicare Advantage business?
A: Medical costs have spiked over the last year as more Medicare Advantage patients return to hospitals for procedures they delayed during the pandemic.
Q: How is CVS addressing these challenges?
A: The company is pursuing store closures and other cost cuts, and its new CEO David Joyner has spent much of his first 100 days at the helm focusing on the company’s insurance unit Aetna.
Global Trends and Politics
WNBA, Scripps Renew Media Rights Deal

Introduction to the WNBA Media Rights Agreement
The WNBA and E.W. Scripps announced a new multiyear media rights agreement to carry Friday night WNBA matchups on Ion. This agreement also includes the "WNBA on Ion" studio show, the first weekly broadcast show dedicated exclusively to WNBA coverage.
Details of the Agreement
The value of the deal was not disclosed, but media reports peg the original deal that expires at the end of the 2025 season at an average of $13 million annually. The WNBA has been airing games on Ion since 2023. This season, the network will broadcast 50 regular season games. Ion is available on pay TV and streaming platforms in more than 128 million homes.
Growth and Popularity of the WNBA
The new agreement comes after Ion has seen huge growth with the WNBA and as the league gains in popularity thanks to stars such as Caitlin Clark and Angel Reese. The network said WNBA Friday Night Spotlight viewership grew 133% year over year and more than 23 million unique viewers tuned into the coverage.
Statements from WNBA and Scripps Executives
"Our robust partnership with the league has flourished, and we are thrilled to solidify ION’s status as the premier Friday night destination for WNBA action for years to come," said Scripps CEO Adam Symson. WNBA Commissioner Cathy Engelbert said the partnership with Scripps has helped the league expand its reach and visibility. "This new multi-year agreement reflects the growing excitement surrounding the league and the rising demand for WNBA games," she said.
Previous Media Rights Deals
The league signed an 11-year media rights deal with Disney, Amazon, and Comcast-owned NBCUniversal last July as part of the NBA’s media rights negotiation. The WNBA’s deal is valued at about $200 million per year.
Conclusion
The new media rights agreement between the WNBA and E.W. Scripps is a significant step forward for the league, providing more exposure and visibility for the players and teams. With the growing popularity of the WNBA, this agreement is expected to bring in more viewers and fans to the league.
FAQs
Q: What is the new media rights agreement between the WNBA and E.W. Scripps?
A: The new agreement is a multiyear deal to carry Friday night WNBA matchups on Ion, including the "WNBA on Ion" studio show.
Q: How many regular season games will Ion broadcast this season?
A: Ion will broadcast 50 regular season games this season.
Q: How many unique viewers tuned into the WNBA Friday Night Spotlight coverage?
A: More than 23 million unique viewers tuned into the coverage.
Q: What is the value of the WNBA’s media rights deal with Disney, Amazon, and Comcast-owned NBCUniversal?
A: The WNBA’s deal is valued at about $200 million per year.
Q: How long is the WNBA’s media rights deal with Disney, Amazon, and Comcast-owned NBCUniversal?
A: The deal is for 11 years.
Global Trends and Politics
Israel-Iran Flight Disruptions

Introduction to Flight Disruptions
Airlines around the world canceled flights to Israel and were skirting a large swath of airspace in the Middle East on Friday after Israel’s overnight missile strikes on Iran. Iran later launched drones toward Israeli territory. The flight map over the Middle East as Iran launches retaliatory attacks on Israel at 19:19 UTC on June 13th, 2025, shows the extent of the disruptions.
Flight Cancellations and Suspensions
Delta Air Lines on Friday afternoon said it was suspending its service to Tel Aviv, Israel, until at least September, just weeks after resuming flights there. It had most recently resumed flights on May 20, and as of last week Delta had said it was planning to increase service to Israel later this year from New York to two daily nonstop flights, "responding to strong winter demand." United Airlines suspended its Tel Aviv flights through July 31, and said in a statement that "we will continue to evaluate an appropriate return date with the safety of our customers and crews as our top priority."
Impact on Air Travel
Both carriers’ Tel Aviv-bound flights turned around over the Atlantic Ocean to return to the New York area after Israel’s strikes overnight. United put 26 of its crew members who were on layover in Israel on Israeli airline El Al to get back to the U.S., a spokesman said. El Al has since suspended service. "Following recent security developments and in accordance with the instructions from the state’s security and aviation authorities to close Israeli airspace, all EL AL and Sundor flights are suspended for the time being," it said on its website.
Airline Reactions and Warnings
The carrier said it won’t take bookings until at least the end of June and warned customers against going to Tel Aviv’s Ben Gurion Airport. "For customers currently abroad, we recommend arranging accommodation until there is a change in security directives," El Al said. "Flights that were en route to Israel have been diverted to land at various EL AL destinations." Israel closed its airspace and suspended flight operations at Ben Gurion International Airport in Tel Aviv, Israel on June 13, 2025.
Global Airline Responses
Turkish Airlines and European budget carrier Wizz Air also suspended Israel flights. Germany’s Lufthansa said it was suspending Tel Aviv and Tehran service until July 31 and flights to Jordan and Lebanon until at least June 20. Emirates said it was canceling service from its base in Dubai to Iraq, Jordan, Lebanon, and Iran. Airlines offered travel vouchers and waived change fees to customers affected by the disruptions.
Conclusion
Escalating military conflicts in the Middle East and Ukraine have forced airlines to repeatedly take longer and more costly routes to avoid conflict zones. The situation highlights the challenges faced by the aviation industry in ensuring safe and uninterrupted travel amidst geopolitical tensions.
FAQs
Q: Why are airlines canceling flights to Israel?
A: Airlines are canceling flights to Israel due to the escalating military conflict between Israel and Iran, which has led to the closure of Israeli airspace and suspension of flight operations at Ben Gurion International Airport.
Q: Which airlines have suspended flights to Israel?
A: Delta Air Lines, United Airlines, El Al, Turkish Airlines, Wizz Air, Lufthansa, and Emirates have suspended flights to Israel.
Q: What alternatives are airlines offering to affected customers?
A: Airlines are offering travel vouchers and waiving change fees to customers affected by the disruptions.
Q: How long will the flight suspensions last?
A: The duration of the flight suspensions varies by airline, with some suspending flights until July 31 and others until at least September.
Q: Are there any other regions affected by flight disruptions?
A: Yes, airlines are also avoiding airspace in Ukraine and other parts of the Middle East due to military conflicts.
Global Trends and Politics
JBS Brazilian Meat Company Goes Public In US

Introduction to JBS
The JBS Greeley meatpacking facility in Greeley, Colorado, US, on Friday, Feb. 28, 2025.
Shares of Brazilian meat giant JBS rose during their U.S. public market debut on Friday.
Initial Public Offering
The opening trade of $13.65 per share values the company at roughly $30 billion, outstripping rival Tyson Foods’ market cap of about $19.82 billion. Shares closed at $13.87, a slight gain for the day.
JBS is now trading on the New York Stock Exchange under the ticker "JBS," a day later than initially expected. The company said it couldn’t conclude certain operational procedures in time to debut on Thursday. Its stock was delisted from the Sao Paolo Exchange in Brazil a week ago as part of the dual-listing plan.
Company Overview
Since its founding more than seven decades ago, JBS has grown to become the world’s largest meatpacking company. Last year, the company reported net revenue of $77.2 billion and net income of $2 billion, according to regulatory filings.
JBS operates a sprawling business worldwide, with significant divisions in Brazil, the U.S. and Australia. The company also owns more than 80% of Pilgrim’s Pride, the U.S. poultry giant.
History of the US Listing
JBS’s U.S. listing is more than 15 years in the making. The company’s U.S. subsidiary first announced plans to go public in 2009, but the move never came to fruition after two postponements. Then, in late 2016, the company said it would have a U.S. initial public offering as part of a broader reorganization strategy. But months later, the Brazilian government began investigating corruption in the meatpacking company — including among JBS and its top executives.
Corruption and Bribery Allegations
J&F Investimentos, the holding company that owns a controlling stake in JBS, paid a $3.2 billion fine in 2017 to settle bribery charges. Former chair Joesley Batista and his older brother CEO Wesley Batista, the company’s top shareholders and the sons of its founder, managed to avoid prison sentences by cooperating with prosecutors. The Batistas and J&F settled with the U.S. Securities and Exchange Commission in 2020 for roughly $27 million.
The Batistas exited J&F in the wake of the scandal. However, they returned to the company’s board last year after being acquitted of insider trading charges.
Recent Developments
More recently, in October, the Brazilian government fined JBS for buying cattle that were allegedly illegally raised in protected land in the Amazon.
The company’s history of corruption and bribery allegations led to opposition to its U.S. listing from lawmakers on the both sides of the aisle, making it look unlikely that regulators would grant their approval.
After President Donald Trump’s reelection, JBS’s subsidiary Pilgrim’s Pride donated $5 million to his inauguration committee, making it the single largest donor. In a statement, the company said it had a "long bipartisan history participating in the civic process" and looked forward to working with the new administration.
The SEC approved JBS’s request to list on the New York Stock Exchange in April. JBS shareholders approved the move by a narrow margin the following month.
Conclusion
In conclusion, JBS has finally made its US public market debut, with shares rising during the first day of trading. The company’s history of corruption and bribery allegations has been a major obstacle to its US listing, but it has now overcome this hurdle. With its significant divisions in Brazil, the US, and Australia, JBS is well-positioned for future growth.
FAQs
Q: What is JBS?
A: JBS is the world’s largest meatpacking company, with significant divisions in Brazil, the US, and Australia.
Q: What was the initial public offering price of JBS shares?
A: The opening trade of $13.65 per share values the company at roughly $30 billion.
Q: Why was JBS’s US listing delayed?
A: JBS’s US listing was delayed due to the company’s history of corruption and bribery allegations, as well as opposition from lawmakers.
Q: Who are the major shareholders of JBS?
A: The Batista family, including Joesley and Wesley Batista, are the top shareholders of JBS.
Q: What is the current market capitalization of JBS?
A: The current market capitalization of JBS is roughly $30 billion.
-
Career Advice6 months ago
Interview with Dr. Kristy K. Taylor, WORxK Global News Magazine Founder
-
Diversity and Inclusion (DEIA)6 months ago
Sarah Herrlinger Talks AirPods Pro Hearing Aid
-
Career Advice6 months ago
NetWork Your Way to Success: Top Tips for Maximizing Your Professional Network
-
Changemaker Interviews5 months ago
Unlocking Human Potential: Kim Groshek’s Journey to Transforming Leadership and Stress Resilience
-
Diversity and Inclusion (DEIA)6 months ago
The Power of Belonging: Why Feeling Accepted Matters in the Workplace
-
Global Trends and Politics6 months ago
Health-care stocks fall after Warren PBM bill, Brian Thompson shooting
-
Global Trends and Politics6 months ago
Unionization Goes Mainstream: How the Changing Workforce is Driving Demand for Collective Bargaining
-
Training and Development6 months ago
Level Up: How Upskilling Can Help You Stay Ahead of the Curve in a Rapidly Changing Industry